NanoVation-GS
NanoVation-GS
Respiratory Monitoring Innovation
Innovative solutions for remote monitoring and disease management of lung diseases and chronic respiratory conditions
Overview
IMPROVING THE MANAGEMENT OF CHRONIC RESPIRATORY CONDITIONS
We provide a reliable solution for monitoring of various chronic respiratory diseases, including COPD and asthma. Our aim is to improve the outcomes of patient's respiratory deterioration by enabling early identification and intervention before the hospitalization is required.
700M respiratory patients
increased by smoking & pollution
High economical burden
Over 500B Euro annual costs
3.9M
annual deaths
3rd leading cause of death
REDUCE UNNECESSARY HOSPITALIZATION AND ASSOCIATED COSTS
Spot-check remote monitoring
Identify/predict deterioration
Enable early intervention
Reduce hospital admissions
More than 1.5M people in EU are annually admitted due to COPD exacerbation.
Over 20% of them are readmitted within 30 days.
The annual spending in EU on COPD exacerbation is more
than 15B Euro.
Our patented technology can identify subtle changes in patient's respiratory condition, enabling healthcare professionals to take proactive measures and prevent patient’s exacerbation and unnecessary hospitalizations.
STAKEHOLDERS
HOSPITALS
Pay for readmissions.
Monitor patients at
homes.
INSURERS
Pay for admissions and management.
Utilize Home HC
services.
HOME HC AGENCIES
Patient management & home monitoring
services for
hospitals
& insurers.
PATIENTS
Quality of life
Expectancy of life
Safety
Quality of care
SenseGuard
TM
SENSEGUARD ENABLES REMOTE RESPIRATORY MONITORING
An innovative nanosensor-based wearable device that enables spot non-invasive monitoring of critical respiratory parameters derived from patients' tidal (normal) breathing, canceling the need for forced expirations.
A COMPREHENSIVE SOLUTION FOR RESPIRATORY MONITORING
Respiration Rate
Inhale/Exhale Ratio (I/E)
Duty Cycle
Variability of Respiratory parameters
Novel and Proprietary Respiratory parameters